Evidence map›Paper›PMID 42236228›Full record

ArticleeNeuro2026

The Subthalamic Nucleus Controls Action Timing under Threat.

Ji Zhou, Muhammad S Sajid, Sebastian Hormigo, Manuel A Castro-Alamancos

Abstract read
In one paragraph

Article in eNeuro, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ji ZhouDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington Connecticut 06030-3401.
Muhammad S SajidDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington Connecticut 06030-3401.ORCID 0009-0005-6405-8126
Sebastian HormigoDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington Connecticut 06030-3401.
Manuel A Castro-AlamancosDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington Connecticut 06030-3401.ORCID 0000-0002-2916-9585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adaptive goal-directed actions performed under threat require caution, often expressed as delayed response timing that balances urgency against error risk by allowing more time for evaluation. Although this temporal regulation is essential for survival, its neural mechanisms remain poorly understood. In mice of either sex, we show that glutamatergic neurons in the subthalamic nucleus (STN) regulate the timing of cued actions that avoid harm. Optogenetic activation of the STN, or its projections to the midbrain but not the globus pallidus, modulates action timing in a frequency-dependent manner, accelerating initiation such that animals lose the ability to respond cautiously, defer actions, or stop ongoing responses. STN excitation can also substitute for a natural cue and prevents the development of cautious responding, indicating a direct role in controlling avoidance action initiation timing. These effects were not driven by aversiveness, as mice did not avoid STN excitation, indicating that stimulation promotes movement rather than negative valence. Together, these findings identify the STN as a key regulator of action initiation timing and establish its midbrain projections as a circuit mechanism for balancing urgency and caution under threat.

Indexed as

Avoidance LearningNeuronsReaction TimeSubthalamic NucleusAnimalsCuesFemaleMaleMiceMice, Inbred C57BLMice, TransgenicNeural PathwaysOptogeneticsaction timingcautious behaviorcued avoidanceresponse inhibitionsubthalamic nucleusthreat-based decision-making

Identifiers

PMID42236228
PMCPMC13246222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.